Beaconcure
Naama Levi Feldman is a product analyst at Beaconcure since May 2022. Prior to this role, Naama served as a research associate, postdoctoral researcher, and PhD student at the Weizmann Institute of Science from 2015 to 2021. Naama also gained experience as a teaching assistant at Ben-Gurion University of the Negev from 2013 to 2014. Educationally, Naama holds a Doctor of Philosophy in Molecular Biology from the Weizmann Institute of Science (2015-2020), a Master of Science in Biology from Ben-Gurion University of the Negev (2013-2014), and a Bachelor's degree in Biology from the same institution (2010-2012).
Beaconcure
BeaconCure leverages artificial intelligence to improve mission-critical business challenges in drug development and regulatory approvals. The Company’s first product is a cloud-based, AI-driven clinical data analytics platform, tailored to improve the quality and significantly reduce cycle time of regulatory submissions.With BeaconCure,companies can rapidly and effectively validate summary data against sources, manage risks, correct inconsistencies in clinical data tables and text, and produce error-free submissions ready for regulatory approval. Pharmaceutical companies and contract research organizations can utilize BeaconCure’s solution to reduce risks and costs and accelerate time to market.BeaconCure is currently collaborating with multinational pharmaceutical companies including Pfizer and clinical research organizations in the U.S, primarily in the Boston area.